EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023)

Braulio Josué Méndez-Sotelo, Marco Antonio Delaye-Martínez, Adolfo Gómez-Quiroz, Sara Alejandra Aguirre-Díaz, Rodrigo Escobedo-Sánchez, José Manuel Ramírez-Rodríguez, Alba Guadalupe Juárez-Lomelí, Claudia Lara-Rangel, Constanza Otero, Nils Ramírez, Luisina Carozza-Renaud, Ixchel Magaña-Matienzo und 3 weitere

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1866897 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Braulio Josué Méndez-Sotelo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectología, Hospital General León, León, Guanajuato, Mexico. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria, Drug Resistance, Bacterial, Bacterial Infections. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance (AMR) is a major global public health threat, responsible for an estimated 4.9 million deaths worldwide and associated with increased morbi-mortality, and healthcare costs. The burden is particularly high in hospital settings, where multidrug-resistant pathogens, including ESKAPE group, are prevalent. However, in Mexico, epidemiological data remain limited. This study aimed to determine the prevalence and distribution of AMR among clinically relevant bacterial pathogens isolated in three hospitals in Guadalajara, Jalisco, Mexico, and to compare resistance patterns across hospital wards and clinical specimen types.

Methods

A retrospective multicenter study was conducted from January 2021 to December 2023. Bacterial identification and susceptibility tests were performed using VITEK 2 and MicroScan WalkAway systems. Results were analyzed using WHONET and interpreted according to CLSI criteria. Clinical specimens included urine, blood, biopsies, abscesses, lower respiratory tract (LRT) specimens, and sterile fluids. Species analyzed included, Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter baumannii and Escherichia coli. Statistical comparisons were performed using R Statistical Software Studio.

Results

A total of 13,336 clinical isolates were analyzed, with E. coli (n= 5,737) and K. pneumoniae (n= 1,738) as the most predominant pathogens. Urine samples were the most frequently collected (n= 4,247). Bloodstream isolates exhibited the highest resistance levels for E. coli and K. pneumoniae . Non-fermenting pathogens showed high resistance in LRT isolates, especially for P. aeruginosa and A. baumannii , with elevated carbapenem resistance. Resistance levels were higher the ICU, particularly for K. pneumoniae , E. cloacae , P. aeruginosa , and A. baumannii . In contrast, the non-ICU settings showed a greater prevalence of ESBL-producing E. coli .

Conclusions

This study reveals substantial AMR burden in Guadalajara, with particularly high levels among bloodstream pathogens, non-fermenters in LRT specimens, and carbapenem-resistant K. pneumoniae and A. baumannii . Resistance patterns varied across hospital wards and specimen types, with higher resistance in ICU. These findings contribute valuable regional data to national AMR monitoring efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteriaDrug Resistance, BacterialBacterial InfectionsDrug Resistance, Multiple, BacterialHumansMexicoRetrospective StudiesMicrobial Sensitivity TestsPrevalenceKlebsiella pneumoniaeHospitalsEscherichia coli

Stichwörter der Autor:innen

ESKAPE pathogensMexicoantimicrobial resistance (AMR)hospitalsmicrobial

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Infectología, Hospital General León, León, Guanajuato, Mexico.
  • Plan de Estudios Combinados en Medicina (PECEM), Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Departamento de Infectología, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Laboratorio de Microbiología Clínica. Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
  • Infectología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
  • Unidad de Vigilancia Epidemiológica, Hospital San Javier, Guadalajara, Jalisco, Mexico.

Zitieren

APA

Méndez-Sotelo, B. J., Delaye-Martínez, M. A., Gómez-Quiroz, A., Aguirre-Díaz, S. A., Escobedo-Sánchez, R., Ramírez-Rodríguez, J. M., Juárez-Lomelí, A. G., Lara-Rangel, C., Otero, C., Ramírez, N., Carozza-Renaud, L., Magaña-Matienzo, I., Garza-González, E., Franco-Cendejas, R., & López-Jácome, L. E. (2026). Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023). Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1866897

Vancouver

Méndez-Sotelo BJ, Delaye-Martínez MA, Gómez-Quiroz A, Aguirre-Díaz SA, Escobedo-Sánchez R, Ramírez-Rodríguez JM, et al. Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023). Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1866897

BibTeX
@article{MndezSotelo2026,
  author = {Méndez-Sotelo, Braulio Josué and Delaye-Martínez, Marco Antonio and Gómez-Quiroz, Adolfo and Aguirre-Díaz, Sara Alejandra and Escobedo-Sánchez, Rodrigo and Ramírez-Rodríguez, José Manuel and Juárez-Lomelí, Alba Guadalupe and Lara-Rangel, Claudia and Otero, Constanza and Ramírez, Nils and Carozza-Renaud, Luisina and Magaña-Matienzo, Ixchel and Garza-González, Elvira and Franco-Cendejas, Rafael and López-Jácome, Luis Esaú},
  title = {Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023)},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1866897}
}
Kostenlos starten →